Downregulation of HLA Class I molecules in the tumour is associated with a poor prognosis in patients with oesophageal squamous cell carcinoma
Open Access
- 7 October 2008
- journal article
- research article
- Published by Springer Science and Business Media LLC in British Journal of Cancer
- Vol. 99 (9), 1462-1467
- https://doi.org/10.1038/sj.bjc.6604715
Abstract
As antigenic peptides in the context of human leukocyte antigen (HLA) class I molecules are recognised by cytotoxic T lymphocytes (CTL), the downregulation of HLA class I molecules is one of the reasons why tumour cells can evade CTL-mediated anti-tumour immunity. In this study, we investigated HLA class I expression in oesophageal squamous cell carcinoma (ESCC) (n=70) and in their metastatic lesions (lymph nodes (n=40) and liver (n=3)), by immunohistochemistry with anti-HLA class I monoclonal antibody (EMR8-5). As a result, the downregulation of HLA class I expression in primary lesions of ESCC was observed in 43%, and that in metastatic lymph nodes was noted in 90%. Furthermore, patients with preserved HLA class I expression in primary tumours showed a better survival in comparison to those with downregulated HLA class I molecules (PP<0.01). In conclusion, the downregulation of HLA class I expression frequently occurred in primary tumour and, to a greater extent, in metastatic lesions of patients with ESCC and was associated with patient survival.Keywords
This publication has 30 references indexed in Scilit:
- Clinical significance of HLA class I heavy chain expression in patients with gastric cancerJournal of Surgical Oncology, 2008
- Clinical impact of HLA class I expression in rectal cancerCancer Immunology, Immunotherapy, 2007
- HLA class I antigen expression is associated with a favorable prognosis in early stage non‐small cell lung cancerCancer Science, 2007
- Association of antigen processing machinery and HLA class I defects with clinicopathological outcome in cervical carcinomaCancer Immunology, Immunotherapy, 2007
- Down-Regulation of HLA Class I Antigen is an Independent Prognostic Factor for Clear Cell Renal Cell CarcinomaJournal of Urology, 2007
- Analysis of HLA class I alterations in tumors: choosing a strategy based on known patterns of underlying molecular mechanismsTissue Antigens, 2007
- Prognostic significance of HLA class I expression in osteosarcoma defined by anti‐pan HLA class I monoclonal antibody, EMR8‐5Cancer Science, 2006
- DNA hypermethylation is a mechanism for loss of expression of the HLA class I genes in human esophageal squamous cell carcinomasCarcinogenesis: Integrative Cancer Research, 2001
- Implications for immunosurveillance of altered HLA class I phenotypes in human tumoursImmunology Today, 1997
- Expression of MHC molecules and ICAM-1 on non-small cell lung carcinomas: Association with early lymphatic spread of tumour cellsEuropean Journal of Cancer, 1996